SL
Therapeutic Areas
Eikonoklastes Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ET-101 (SynCav1) | Amyotrophic Lateral Sclerosis (ALS) | Pre-clinical |
| ET-101 Platform | Parkinson’s, Huntington’s, MS, TBI, Alzheimer’s | Discovery |
| Drug | Indication | Phase |
|---|---|---|
| ET-101 (SynCav1) | Amyotrophic Lateral Sclerosis (ALS) | Pre-clinical |
| ET-101 Platform | Parkinson’s, Huntington’s, MS, TBI, Alzheimer’s | Discovery |